RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
Globenewswire·2025-10-01 10:01

Core Viewpoint - RetinalGenix Technologies Inc. and RGEN Inc. have formed a strategic partnership aimed at enhancing early detection and risk prediction for neurodegenerative, systemic, and retinal diseases through advanced retinal imaging and DNA genotyping [1][2][4] Group 1: Partnership Objectives and Innovations - The collaboration seeks to integrate advanced retinal imaging with clinical-grade DNA genotyping to develop predictive models for diseases such as Age-Related Macular Degeneration (AMD), Glaucoma, and Alzheimer's Disease [2][4] - This partnership combines RetinalGenix's high-resolution retinal imaging platform with RGEN's CLIA-certified DNA testing capabilities, creating a dual-pronged diagnostic model that captures both retinal changes and DNA variants [3][4] - The integrated approach is expected to improve patient outcomes and reduce healthcare system burdens by enabling earlier intervention and disease management [4] Group 2: Future Steps and Applications - RetinalGenix plans to commercialize a combined screening tool for use in primary care offices, clinics, and remote monitoring locations, as well as to establish partnerships with healthcare payers for preventative care coverage [5] - The partnership aims to expand its platform to address other age-related and neurodegenerative conditions in the future [5] - The collaboration is positioned to redefine the detection and management of chronic and ocular diseases in at-risk populations, paving the way for predictive, preventive, and personalized medicine [5][6] Group 3: Company Backgrounds - RetinalGenix Technologies Inc. focuses on early disease detection and improving patient outcomes through genetic screening and advanced imaging technologies [6] - RGEN Inc. specializes in genetic research and testing, providing genomic solutions that support disease prevention and personalized wellness [7][8]